Select Page

Gene Editing Causing Challenges for EU Policymakers

After a quarter century of conflict over genetically modified foods, it’s understandable that initial reactions to gene editing—the technical process of editing or removing specific genes of an organism—being applied to produce and livestock have been met with...

Intellia Therapeutics Raises $108M in Upsized IPO

Novartis-backed, preclinical upstart Intellia Therapeutics ($NTLA) announced May 6th that it’s going for the top range of its IPO, selling 6 million shares at $18 a share to raise a total of $108 million. Founded in 2014, Intellia quickly caught the attention of...

Evaluating Debt When Investing in Biotech

Biotech companies pour millions of dollars into research programs every year, but the outcome is never guaranteed. The money used to fund this research can, in part, come from issuing stock or taking on debt. How much debt should be a concern for investors. Debt...

Biotech’s Next Innovation: Lab-Grown Meat

The biotech industry has some of the most interesting/bizarre trends you’ll find when researching investment opportunities. From prosthetic limbs to gene editing, biotechnology pushes the limits of what could be every day. One of the latest interesting trends to...

Cancer Researchers Produce Best CAR-T Results Yet

Scientists claim to have produced “extraordinary” results that exceeded even the expectations of the researchers themselves using T-cell therapy to treat cancer in recent months. The research group, led by Dirk Busch at the Technical University of Munich...

How Biotech is Changing Cancer Treatment

According to Cancer Research UK, 50% of people born after 1960 in the UK will be diagnosed with some form of cancer during their lifetime. Of those 50%, only half will survive cancer for 10 or more years. With more than 200 different types of cancer, finding new...

U.K. Approves First Studies of CRISPR on Human Embryos

In my last blog post, I detailed the legal battle currently taking place over the biggest scientific breakthrough of 2015, a controversial gene edited technology called CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats.) On February 1st, the United...

New Reforms on Taxation of Asset Manager Pay

The UK government has been making a lot of changes lately to how those in finance do business. From separating divisions of big banks to sweeping reviews of the asset management industry, a lot has been changing recently. In an effort to crack down on tax dodging, the...